Latest Alzheimer's disease News

This image released by Netflix shows Tim Hollingsworth, chef and owner of Otium in Los Angeles appears in a scene from the cooking competition series

Sharing a family meal can help those with dementia connect

Dec. 16, 2019 9:17 AM EST

Long before Tim Hollingsworth earned the James Beard Foundation's Rising Star Chef of the Year award and served as chef de cuisine at French Laundry, he was learning to cook by his mother's side at home. As a kid, Hollingsworth would measure ingredients to help his mom make dinner, and he'd talk with her and...

Charles Flagg, who is stricken with Alzheimer's disease, sits for an infusion while participating in a study on the drug Aducanumab at Butler Hospital in Providence, R.I. New results were released on the experimental medicine whose maker claims it can slow the decline of Alzheimer's disease, the most common form of dementia. (AP Photo/Charles Krupa)

Experts split sharply over experimental Alzheimer’s drug

Dec. 5, 2019 3:43 PM EST

SAN DIEGO (AP) — A company that claims to have the first drug to slow mental decline from Alzheimer's disease made its case to scientists Thursday but left them sharply divided over whether there’s enough evidence of effectiveness for the medicine to warrant federal approval. Excitement and...

This undated photo provided by Acadia Pharmaceuticals Inc. shows a bottle of Nuplazid, a drug that was tested for treating psychosis related to dementia. If regulators agree, the drug could become the first treatment specifically for dementia-related psychosis and the first new medicine for Alzheimer's in nearly two decades. Results from a study on the drug were disclosed Wednesday, Dec. 4, 2019, at an Alzheimer's conference in San Diego.  (Acadia Pharmaceuticals Inc. via AP)

Drug can curb dementia’s delusions, researchers find

Dec. 4, 2019 8:53 PM EST

SAN DIEGO (AP) — A drug that curbs delusions in Parkinson's patients did the same for people with Alzheimer's disease and other forms of dementia in a study that was stopped early because the benefit seemed clear. If regulators agree, the drug could become the first treatment specifically for...

Lawyers say federal death row prisoner has Alzheimer’s

Nov. 27, 2019 1:54 PM EST

WASHINGTON (AP) — Lawyers for a federal death row inmate convicted of rape and murder have asked a federal judge to halt his scheduled execution next month because the prisoner has Alzheimer’s disease and schizophrenia. Wesley Ira Purkey’s lawsuit was filed late Tuesday in Washington. His...